Navigation Links
Retired Supreme Court Justice Sandra Day O'Connor and Former House Speaker Newt Gingrich Address Senate Special Committee on Aging, Calling for Urgent Action Against Alzheimer's Disease
Date:5/14/2008

we want real change in the devastating trajectory of this disease, we need real change in our strategies to overcome it."

The Alzheimer's Study Group has identified five specific issues that will form the core of its strategic recommendations. Because the Group's approach is to integrate various perspectives, it will announce recommendations in the form of a coordinated national plan in early 2009. The Group has created a task force to develop recommendations for each of these issues:

-- Encouraging Collaboration among Researchers. Scientific researchers

from academia, government, and industry need the tools and incentives

to scan the growing body of Alzheimer's research for relevant

breakthroughs and more efficiently collaborate

on solutions, regardless of organizational boundaries.

-- Improving Alzheimer's Clinical Trials. Alzheimer's clinical trials

must be better supported and coordinated to reduce delays, improve

efficiency, and ultimately allow the faster identification of new

promising treatments.

-- 'Rapid Learning' from Large Electronic Health Datasets. Cutting edge

tools and methods of "data mining" have the potential to revolutionize

how we prevent, treat and care for Alzheimer's through a 21st century

version of the Framingham Heart Study.

-- Integrating a Community-Based Care Model. Innovative approaches to

care that better support patients and families and help manage costs

must be developed from best case practices, and made available to all

Americans.

-- Providing Better Information to Policymakers. Government leaders must

be given meaningful and timely information on the mounting impact and

potential responses to Alzheimer's if they hope to assess progress,

set funding priorities, and exercise strategic oversight.

"We need to move
'/>"/>

SOURCE The Alzheimer's Study Group
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
4. Agencourt Genomic Services is Key Collaborator in New Research That Further Defines Landscape of Breast and Colon Cancers
5. U.S. District Court Decision About Eisais Legal Action Over Aricept ODT(R) ANDA Filing
6. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
7. AstraZeneca Response to February 21, 2008 Ruling In Re: Alabama Medicaid Pharmaceutical AWP Litigation - cv2005-219 - Circuit Court of Montgomery, Alabama
8. Results of Court Meeting and Extraordinary General Meeting - Shareholders Approve Scheme of Arrangement and New Share Plans
9. Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits With the U.S. Department of Justice Relating to Anzemet(R)
10. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
11. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... 15 , ... Evaluate the Ability of,Cardiopoietic Cells to Restore Cardiac ... a leading Belgian biotechnology company specialising,in cell-based therapies ... it has completed, two months ahead of schedule,enrolment ... II/III trial of C-Cure, a,unique stem cell therapy ...
(Date:12/14/2009)... BOULDER, Colo. and THOUSAND OAKS, Calif., Dec. 14 ... ) and Amgen Inc.(Nasdaq: AMGN ) today ... Amgen exclusive worldwide rights to Array,s small-molecule glucokinase ... a Phase 1 clinical trial in patients with ... terms of the agreement, Array will receive an ...
(Date:12/14/2009)... International, Inc. (Pink Sheets: DYAI) ("Dyadic") announced today ... Scripps Research Institute ("Scripps") by entering into an ... Dyadic,s patented and proprietary C1 fungus ("C1"). ,, ... relationship between the two organizations which began in ... the C1 genome for the first time. The ...
(Date:12/14/2009)... The third edition of Infusion Nursing: ... by the Infusion Nurses Society (INS), includes Totect(®), ... Anthracyclines are a group of chemotherapy medications including ... used in the treatment of various types of ... According to the INS publication: "In September 2007, ...
Breaking Biology Technology:Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5
... SuperGen Inc.,(Nasdaq: SUPG ), a pharmaceutical company ... for solid tumors and,hematological malignancies, invites all interested parties ... Annual Analyst Day beginning at 9:30 a.m. ET,(6:30 a.m. ... on Tuesday,April 29, 2008., Investors and interested parties ...
... Renovis, Inc.,(Nasdaq: RNVS ), today announced that Glass ... ISS/Risk Metrics in recommending that Renovis,stockholders vote "FOR" the ... the Special Stockholders Meeting scheduled for May,1, 2008. In ... will be,converted into the right to receive the equivalent ...
... of Bioterrorism, Says UK Board ... Member General Lord Guthrie, BOSTON, April ... and deploy technology that can neutralize and destroy,a biohazardous substance while ... with General Lord Guthrie,former chief of the British Defense Staff, to ...
Other Biology Technology:Glass Lewis & Co. Recommends Renovis Shareholders Vote For Merger With Evotec 2Glass Lewis & Co. Recommends Renovis Shareholders Vote For Merger With Evotec 3Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection 2Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection 3
(Date:12/14/2009)... defining feature of humans. That,s until examples of tool use ... array of other mammals. Now, a report in the December ... publication, adds an octopus to the growing list of tool ... trick that the researchers call stilt walking. In it, the ... makes its eight arms rigid, and raises the whole assembly ...
(Date:12/13/2009)... resolved a question about how a popular class ... biosensors that reveal previously hidden components of chemical ... and hallucinations characterize the illness, people with schizophrenia ... in a particular order, difficulties that interfere with ... well, said Lee Schroeder, a student in the ...
(Date:12/11/2009)... increases, growers are being challenged to bring consistently ... bottom line, orchard owners are experimenting with new ... labor costs. , Hand thinning, a common practice ... is among the most labor-intensive of orchard practices, ... and, ultimately, prices paid by consumers. A research ...
Breaking Biology News(10 mins):Tool use in an invertebrate: The coconut-carrying octopus 2New biosensors reveal workings of anti-psychotic drugs in the living brain 2Horizontal string trimmer reduces labor costs, increases peach size 2Pragmedic Implements World Class Healthcare Solution for Emaar Healthcare 14646 1Pragmedic Implements World Class Healthcare Solution for Emaar Healthcare 14646 2Rogan Delft Approves Matrox Xenia Series for Use With Zillion Suite 5831 1Rogan Delft Approves Matrox Xenia Series for Use With Zillion Suite 5831 2Rogan Delft Approves Matrox Xenia Series for Use With Zillion Suite 5831 3Practice changing cancer studies presented at major cancer meeting 60320 1Practice changing cancer studies presented at major cancer meeting 60320 2
... test for the two strains of human papillomavirus responsible for ... assay uses a cervical scraping, like that for a liquid-based ... responsible for 70 percent of cervical cancers, says Dr. Daron ... Cancer Prevention Center at the Medical College of Georgia. ...
... make cholesterol, a team of scientists has discovered ... production and potentially drug metabolism. , The collaborative ... of Medicine, Vanderbilt University, Indiana University and Eli ... of Cell Metabolism. , “Dap1 controls ...
... agriculture now will we meet the acute water-environment-poverty challenges facing ... land and human resources it is possible to produce enough ... food production and environmental trends will lead to crises in ... General of the International Water Management Institute. , This is ...
Other Biology News:New test for most virulent HPV strains under study 2New test for most virulent HPV strains under study 3Primitive yeast yields secrets of human cholesterol and drug metabolism 2Living with water scarcity -- world must act now 2Living with water scarcity -- world must act now 3Living with water scarcity -- world must act now 4Living with water scarcity -- world must act now 5
... up to 6 strain chambers with precise uniaxial ... design ensures that cells grow over long periods ... This unit allows you to control the frequency ... unique strain settings. The instrument fits in a ...
... The Guava PCA-96 systems provide automated, ... a tray of microcentrifuge tubes. This flexible ... ideal for screening in basic research, target ... Like it's smaller cousin, the Guava PCA-96 ...
... 250 g monoclonal antibody irreversibly crosslinked ... ~13 g of PDH complex from heart ... bovine heart mitochondria for control immunocapture. ,The ... isolation of PDH from small amounts of ...
... cells permits studies of protein-protein interactions, protein ... transcription factor-mediated gene regulation. The most rapid ... specific protein in a mammalian cell is ... cell. ProteoJuice Protein Transfection Reagent is an ...
Biology Products: